Burden of pneumococcal disease among adults in Southern Europe (Spain, Portugal, Italy, and Greece): a systematic review and meta-analysis

Navarro-Torné, Adoración; Montuori, Eva Agostina; Kossyvaki, Vasiliki; Méndez, Cristina

doi:10.1080/21645515.2021.1923348

Cited by 9 publications

(12 citation statements)

References 244 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The PVC vaccine was included in the NIP in 2006 with the recommendation of three doses for PCV (two shots in the first year of life and the third in the second year) and one shot over the fifth year. The suboptimal immunization rate for PVC vaccine highlights the need for higher coverage among young adults, since the disease is still prevalent in Greece [ 46 ].…”

Section: Discussionmentioning

confidence: 99%

Vaccination Coverage during Childhood and Adolescence among Undergraduate Health Science Students in Greece

et al. 2022

View full text Add to dashboard Cite

High rates of vaccination coverage in childhood represent one of the most important cost-effective tools of primary prevention and have substantially reduced the incidence of and mortality from vaccine-preventable diseases globally. Vaccination coverage of young people has not been well estimated in Greece. Anonymous self-completed questionnaires and the participants’ Child Health Booklet were used to estimate complete vaccination coverage of mandatory vaccinations against vaccine-preventable diseases of undergraduate students at the University of West Attica during the academic year 2020–2021. Student’s t-tests were used to estimate mean values. Overall, 79% (95% CI: 78–81%) of study participants were fully vaccinated. This coverage was lower in males especially for vaccines that should be done during childhood (p = 0.045). High vaccination percentage (>90%) was observed for the meningococcus group A, C, W135, Y, measles-mumps-rubella, hepatitis B and meningitis C vaccine. Nevertheless, suboptimal coverage was assessed for the booster dose of tetanus, diphtheria, pertussis, for the human papillomavirus vaccine among girls, for the tuberculosis, for the meningococcus group B, for the pneumococcal, and for the seasonal influenza vaccines. In conclusion, the promotion of routine vaccination programs for young adults needs to be strengthened. An identification system for under-vaccinated students, an efficient reminder system and university campus vaccine program practices should be established, particularly among males.

show abstract

Section: Discussionmentioning

confidence: 99%

Vaccination Coverage during Childhood and Adolescence among Undergraduate Health Science Students in Greece

et al. 2022

View full text Add to dashboard Cite

show abstract

“…During the past decades, likely related to differences in vaccination practices and smoking, the role of pneumococcus as a causative microorganism in pneumonia cases in developed countries has clearly declined (representing currently less than 10–15% of overall pneumonia cases in North America and Europe). [29] , [30] Therefore, the potential value of pneumococcal vaccination in reducing all-cause pneumonia has also decreased, and it would be relatively low at present. On this concern, pneumococcal pneumonia represented 14.9% (3592/24,136) of overall pneumonia cases in the present study, supporting that the role of pneumococcus as causative pathogen of pneumonia has also declined in recent years in our setting (where pneumococcus represented near 40% of community-acquired pneumonia cases at the beginning of the present century).…”

Section: Discussionmentioning

confidence: 99%

Evaluating clinical effectiveness and impact of anti-pneumococcal vaccination in adults after universal childhood PCV13 implementation in Catalonia, 2017–2018

et al. 2023

View full text Add to dashboard Cite

“…A systematic review and meta-analysis conducted on articles published from Southern Europe reported an incidence of invasive pneumococcal disease (IPD) in adults to be 15.08 per 100,000 in Spain and 2.56 per 100,000 in Italy. The same study reported an incidence of 19.59 per 100,000 in Spain and 2.19 per 100,000 in Italy for pneumococcal pneumonia [ 9 ]. An Australian study reported hospitalization incidence due to pneumococcal pneumonia to be 274 per 100,000 population in 2011–2012 in adults aged ≥65 years.…”

Section: Burden Of Pneumococcal Disease In Middle East/lebanonmentioning

confidence: 99%

“…They also reported a case fatality rate of 6.1% between 2004 to 2012 [ 1 ]. A decline in the burden of pneumococcal disease has been reported by various studies due to the introduction of vaccination [ 2 , 9 ].…”

Section: Burden Of Pneumococcal Disease In Middle East/lebanonmentioning

confidence: 99%

Pneumococcal Disease in High-Risk Adults in Lebanon: Expert Opinion

et al. 2022

View full text Add to dashboard Cite

Pneumococcal disease affects people across all ages but is more prevalent in young children and the elderly. Despite the availability of the pneumococcal vaccine for adults, the disease burden and mortality associated with it remains a challenge. A few studies conducted in Lebanon have reported epidemiology of pneumococcal disease, concurring the high burden among adults and older adults in the region. The pneumococcal vaccine is a part of the routine immunization schedule for children, but there are no recommendations for adult vaccination. A medical advisory board was hence conducted in September 2020 to discuss the burden of pneumococcal disease (PD) among adults in Lebanon. The participants were experts from the fields of internal medicine, family medicine, hematology, cardiology, oncology, endocrinology, pulmonology, and infectious diseases. The experts reached a consensus that there is a need to take steps to increase the rate of adult vaccination uptake and create awareness among physicians, pharmacists, caregivers, and patients. The physicians should be trained on adult immunization and should actively discuss the importance of the pneumococcal vaccine, especially with high-risk adult patients. Implementing adult vaccination as a routine practice and involving various stakeholders to address the gaps can help in reducing the burden of pneumococcal disease in adults.

show abstract

Burden of pneumococcal disease among adults in Southern Europe (Spain, Portugal, Italy, and Greece): a systematic review and meta-analysis

Cited by 9 publications

References 244 publications

Vaccination Coverage during Childhood and Adolescence among Undergraduate Health Science Students in Greece

Vaccination Coverage during Childhood and Adolescence among Undergraduate Health Science Students in Greece

Evaluating clinical effectiveness and impact of anti-pneumococcal vaccination in adults after universal childhood PCV13 implementation in Catalonia, 2017–2018

Pneumococcal Disease in High-Risk Adults in Lebanon: Expert Opinion

Contact Info

Product

Resources

About